Sanofi Q3 2012 - Interview With CFO Jérôme Contamine

Sanofi, a global and diversified healthcare leader, reports results for the third-quarter of 2012. Jérôme Contamine, Chief Financial Officer of Sanofi, comments on results and outlook.

Click to watch the video: http://bit.ly/T8WMTB

Topics covered in the interview include:

- Q3 2012 Results- Diabetes- Multiple Sclerosis- Rare Diseases- Vaccines- Austerity in Europe- Emerging Markets- R&D pipeline

About Sanofi

Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

Company website: www.sanofi.com

Copyright Business Wire 2010

If you liked this article you might like

With Eyes on Solar Eclipse, Wall Street Stumbles Yet Again

Renewed Speculation of ECB Tightening Boosts the Euro

European Banks Stocks Rebound as Investors Put Risk Bank Into Play